Metropolitan Life Insurance Company (MetLife)’s Neogen NEOG Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio NEOG Stock Details NEOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-11,459	Closed	-$181K	–	1363
2024 Q1	$181K	Sell	11,459 -1,089	-9%	-$18.2K	0.01%	757
2023 Q4	$252K	Hold	12,548	–	–	0.01%	640
2023 Q3	$233K	Buy	12,548 +514	+4%	+$11.2K	0.01%	614
2023 Q2	$262K	Hold	12,034	–	–	0.01%	581
2023 Q1	$223K	Sell	12,034 -1,373	-10%	-$25.8K	0.01%	631
2022 Q4	$204K	Buy	13,407 +6,816	+103%	+$97.1K	0.01%	705
2022 Q3	$92.1K	Hold	6,591	–	–	﹤0.01%	1067
2022 Q2	$159K	Hold	6,591	–	–	0.01%	816
2022 Q1	$203K	Sell	6,591 -38,867	-86%	-$1.4M	0.01%	808
2021 Q4	$2.06M	Sell	45,458 -396	-0.9%	-$16.9K	0.03%	512
2021 Q3	$1.99M	Sell	45,854 -1,706	-4%	-$74.2K	0.03%	508
2021 Q2	$2.19M	Buy	47,560 +472	+1%	+$21.8K	0.03%	484
2021 Q1	$2.09M	Sell	47,088 -340	-0.7%	-$14.3K	0.03%	495
2020 Q4	$1.88M	Buy	47,428 +16,958	+56%	+$630K	0.03%	507
2020 Q3	$1.19M	Sell	30,470 -1,600	-5%	-$61.2K	0.02%	639
2020 Q2	$1.24M	Buy	32,070 +782	+2%	+$26.4K	0.02%	611
2020 Q1	$1.05M	Sell	31,288 -1,404	-4%	-$46.1K	0.02%	658
2019 Q4	$1.07M	Sell	32,692 -558	-2%	-$18.3K	0.02%	858
2019 Q3	$1.13M	Buy	33,250 +1,196	+4%	+$41.4K	0.02%	794
2019 Q2	$995K	Hold	32,054	–	–	0.02%	898
2019 Q1	$920K	Hold	32,054	–	–	0.02%	928
2018 Q4	$914K	Buy	32,054 +306	+1%	+$9.57K	0.02%	856
2018 Q3	$1.14M	Sell	31,748 -386	-1%	-$16.5K	0.02%	866
2018 Q2	$1.29M	Buy	32,134 +414	+1%	+$15.3K	0.02%	794
2018 Q1	$1.06M	Buy	31,720 +427	+1%	+$12.9K	0.02%	873
2017 Q4	$965K	Buy	+31,293	New	+$948K	0.01%	907
2017 Q3	–	Sell	-68,443	Closed	-$1.77M	–	2505
2017 Q2	$1.77M	Hold	68,443	–	–	0.01%	988
2017 Q1	$1.68M	Hold	68,443	–	–	0.01%	1015
2016 Q4	$1.69M	Sell	68,443 -1,349	-2%	-$30K	0.01%	1036
2016 Q3	$1.46M	Sell	69,792 -637	-0.9%	-$13.6K	0.01%	1078
2016 Q2	$1.49M	Hold	70,429	–	–	0.01%	1049
2016 Q1	$1.33M	Sell	70,429 -91	-0.1%	-$1.73K	0.01%	1049
2015 Q4	$1.5M	Hold	70,520	–	–	0.01%	1001
2015 Q3	$1.19M	Sell	70,520 -760	-1%	-$15K	0.01%	1107
2015 Q2	$1.27M	Sell	71,280 -3,752	-5%	-$65K	0.01%	1148
2015 Q1	$1.31M	Sell	75,032 -520	-0.7%	-$9.52K	0.01%	1060
2014 Q4	$1.41M	Hold	75,552	–	–	0.01%	1123
2014 Q3	$1.12M	Sell	75,552 -3	-0%	-$47	0.01%	1206
2014 Q2	$1.15M	Hold	75,555	–	–	0.01%	1267
2014 Q1	$1.27M	Hold	75,555	–	–	0.01%	1181
2013 Q4	$1.29M	Sell	75,555 -1	-0%	-$17	0.01%	1184
2013 Q3	$1.15M	Hold	75,556	–	–	0.01%	1206
2013 Q2	$1.05M	Buy	+75,556	New	+$997K	0.01%	1205

Other funds holding NEOG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s NEOG Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Neogen (NEOG) in Q2 2024, closing a stake of 11,459 shares — an estimated $181K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in NEOG in Q2 2013 and held it in 43 quarters. The position peaked at $2.19M in Q2 2021. 345 funds tracked by Wall St. Rank hold NEOG as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Neogen position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 11,459 Neogen shares in Q2 2024, an estimated $181K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Neogen in Q2 2013 and held it in 43 quarters.
Metropolitan Life Insurance Company (MetLife)'s Neogen position peaked at $2.19M in Q2 2021.
345 funds tracked by Wall St. Rank held Neogen as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.